Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis

European Journal of Endocrinology

Volumn 142, Issue 4, 2000, Pages 365-372

  Bullmann, Catharina ^a   Faust, Michael ^a   Hoffmann, Axel ^a   Heppner, Christina ^b   Jockenhövel, Friedrich ^a   Müller Wieland, Dirk ^a   Krone, Wilhelm ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR; CYCLOPHOSPHAMIDE; DESMOPRESSIN; DEXAMETHASONE; GADOLINIUM; GONADORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DETERIORATION; DIABETES INSIPIDUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPOGONADISM; HYPOPHYSITIS; HYPOPITUITARISM; LYMPHOCYTIC INFILTRATION; MALE; MENINGOENCEPHALITIS; PRIORITY JOURNAL; REMISSION; SARCOIDOSIS;

EID: 0034013734     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1420365     Document Type: Article

References (31)

1. Chapelon C, Ziza JM, Piette JC, Levy Y, Raguin G, Wechsler B et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine 1990 69 261-276.
2. Oksanen V. Neurosarcoidosis: clinical presentations and course in 50 patients. Acta Neurologica Scandinavia 1986 73 285-290,
3. Stern BJ, Drumholz A, Johns C, Scott P & Nissim J. Sarcoidosis and its neurological manifestations. Archives of Neurology 1985 42 909-917.
4. Graham E & James DG. Neurosarcoidosis. Sarcoidosis 1988 5 125-131.
5. Ezzat S & Josse RG, Autoimmune hypophysitis. Trends in Endocrinology and Metabolism 1997 8 74-80.
6. Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E & Ezzat S. Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings. Journal of Clinical Endocrinology and Metabolism 1995 80 2302-2311.
7. Pressman EK, Zeidman SM, Reddy UM, Epstein JI & Brem H Differentiating lymphocytic adenohypophysitis from pituitary adenoma in the peripartum patient. Journal of Reproductive Medicine 1995 40 251-259.
8. Donald RA. The assessment of pituitary function. Clinical Biochemistry 1990 23 23-30.
9. Robertson GL. Diabetes insipidus. Endocrinology and Metabolism Clinics of North America 1995 24 549-572.
10. Fukata J, Shimizu N, Imura H, Hibi I, Tanaka K, Tanaka T et al. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders. Endocrine Journal 1993 40 597-606.
11. Vance ML. Hypopituitarism. New England Journal of Medicine 1994 330 1651-1662.
12. Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A et al. Influence of disease manifestation and antineutrophil cytoplasmatic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis and Rheumatism 1994 47 919-924.
13. Sharma OP & Sharma AM. Sarcoidosis of the nervous system. A clinical approach. Archives of Internal Medicine 1991 151 1317-1321.
14. Bleisch VR & Robbins SL. Sarcoid-like granulomata of the pituitary: a course of pituitary insufficiency. Archives of Internal Medicine 1952 89 877-892.
15. Chiang R, Marshall MC, Rosman PM, Hotson G, Mannheimer E & Wallace EZ. Empty sella turcica in intracranial sarcoidosis. Pituitary insufficiency, primary polydipsia, and changing neuroradiologic findings. Archives of Neurology 1984 41 662-665.
16. Chapellan LJI, Olmedo LC, Martin JM, Marin MM, Villanueva MG, Zarza FM et al. Intrasellar mass with hypopituitarism as a manifestation of sarcoidosis. Journal of Neurosurgery 1990 73 283-286.
17. Féry F, Plat L, van de Borne P, Copgan E & Mockel J. Impaired cointerregulation of glucose in a patient with hypothalamic sarcoidosis. New England Journal of Medicine 1999 340 852-856.
18. Loh K-C. Green A, Dillon WP, Fitzgerald PA, Weidner N & Tyrell JB. Diabetes insipidus from sarcoidosis confined to the posterior pituitary. European Journal of Endocrinology 1997 137 514-519.
19. Mißler U, Mack M, Nowak G, Müller-Esch G, Reusche E, Borgis K-J et al. Pituitary sarcoidosis. Klinische Wochenschrift 199068 342-345.
20. Oksanen V, Grönhagen-Riska C, Fyhrquest F & Somer H. Systemic manifestation and enzyme studies in sarcoidosis with neurologic involvement. Acta Medica Scandinavia 1985 218 123-127.
21. Lawrence EC, Brousseau KP, Berger MB, Kurman CC, Marcon L & Nelson DL. Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis. American Reviews of Respiratory Disease 1988 137 759-764.
22. Lieberman J. Evaluation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. American Journal of Medicine 1975 59 359-560.
23. Selroos OB. Biochemical markers in sarcoidosis. Critical Reviews in Clinical Laboratory Sciences 1986 24 185-216.
24. Strausz J, Müller-Quernheim J & Ferlinz R. Sezernierter Interleukin-2-Rezeptor als Aktivitätsparameter der Sarkoidose. Deutsche Medizinische Wochenschrift 1989 114 744-749.
25. Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Schlaak M & Müller-Quernheim J. Sarcoidosis: TNF-α release from alveolar macrophages and serum level of sIL-2R are prognostic markers. American Journal of Respiratory and Critical Care Medicine 1997 156 1586-1592.
26. Lexa F & Grossmann RI. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. American Journal of Neuroradiology 199 3 15 973-982.
27. Scott TF. Neurosarcoidosis: progress and clinical aspects. Neurology 1993 43 8-12.
28. Braumgartner I, Hochstetter Av, Baumert B, Luetolf U & Follath F. Langerhans'-cell histiocytosis in adults. Medical and Pediatric Oncology 1997 28 9-14.
29. Agbogu BN, Stern BJ, Sewell C & Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Archives of Neurology 1995 52 875-879.
30. Lower EE, Broderick JP, Brott TG & Baughman RP. Diagnosis and management of neurological sarcoidosis. Archives of Internal Medicine 1997 157 1864-1868.
31. Guillevin L, Cordier J-F, Lhote F, Cohen P, Jarrousse B, Royer I et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide in the treatment of generalised Wegener's granulomatosis. Arthritis and Rheumatism 1997 40 2187-2198.